Bone Marrow-Sparing Pelvic Radiotherapy: Clinical Evidence, Dosimetric Constraints, and Clinical Outcomes.

Area of Science:

• Oncology
• Radiation Oncology
• Hematology

Background:

• Pelvic radiotherapy is a common cancer treatment.
• Incidental irradiation of pelvic bone marrow causes hematologic toxicity.
• Strategies to spare bone marrow are under investigation.

Purpose of the Study:

• To review the biological basis of radiation-induced marrow injury.
• To overview current bone marrow identification and sparing techniques.
• To discuss the clinical relevance of marrow-sparing strategies in pelvic cancers.

Main Methods:

• Narrative review of existing literature.
• Analysis of biological mechanisms of radiation injury.
• Evaluation of current and emerging bone marrow sparing techniques.
• Assessment of clinical data on pelvic cancer treatment outcomes.

Main Results:

• Limited bone marrow irradiation can decrease treatment-related hematologic toxicity.
• Marrow sparing may be particularly beneficial in combined modality therapy.
• Potential benefits for immune preservation exist.
• Impact on long-term oncologic outcomes is not yet established.

Conclusions:

• Bone marrow sparing in pelvic radiotherapy shows promise for reducing toxicity.
• Further prospective research is needed to optimize techniques and confirm oncologic efficacy.
• Defining the role of bone marrow preservation is crucial for improving patient care.